21 March 2023 - further investment in Alliance Pharma
The company has announced that it has added to its holding in Alliance Pharma, the AIM- listed international healthcare group, through the acquisition of another 10.16m shares at an average price of 66.83p. This takes its holding in the company to almost 29m shares representing 5.36% of the equity. Co-incidentally, Alliance Pharma has announced its results today and we have commented on these elsewhere. Shares in LDG remain at a significant discount to its net asset value per share and the company is therefore looking to buy back . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
